Unknown NA INTERVENTIONAL 1-arm NCT03715686

To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph Nodes

To Accurately Assess Lymph Node Response to Neoadjuvant Chemotherapy by Wire Localization of Clip-marked Axillary Lymph Nodes in Breast Cancer Patients

Sponsor: Peking University

Conditions Lymph Node Metastases Neoadjuvant Chemotherapy Neoplasm, Breast Response

Interventions wire localization

Updated 7 times since 2018 Last updated: Nov 26, 2021 Started: Oct 20, 2018 Primary completion: Jun 20, 2022 Completion: Jun 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Lymph Node Metastases and Neoadjuvant Chemotherapy and is currently ongoing. Peking University leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Dec 2021 — Oct 2023 [monthly]

Recruiting NA
Jan 2021 — Dec 2021 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Nov 2020 — Jan 2021 [monthly]

Recruiting NA
Nov 2018 — Nov 2020 [monthly]

Recruiting NA

First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking University

Data source: Peking University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China